Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins
- 82 Downloads
Background and objective
Elderly patients may be at higher risk of drug-drug interactions (DDIs) because of polypharmacy. This study evaluated age-specific differences in the prevalence of clinically relevant potential DDIs (pDDIs) in ambulatory dyslipidaemic patients treated with an HMG-CoA reductase inhibitor (statin). We hypothesised that elderly patients are at higher risk for pDDIs because of the presence of more drugs and drugs with a higher potential for DDIs in this age group.
A total of 2742 dyslipidaemic ambulatory patients treated with a statin were included in this cross-sectional study. Drug treatment was screened for clinically relevant pDDIs using an electronic drug interaction program (DRUG-REAX® System).
The study sample consisted of 483 (17.6%) patients aged ≤54 years, 732 (26.7%) aged 55–64 years, 924 (33.7%) aged 65–74 years and 603 (22.0%) patients aged ≥75 years. Patients ≥75 years had significantly more pharmacologically active substances prescribed than patients aged ≤54 years (mean 5.8 vs 3.8, respectively; p < 0.001). Cardiovascular diseases such as coronary heart disease, heart failure or arrhythmias were also significantly more prevalent in patients aged ≥75 years than in younger patients. The overall prevalence of pDDIs increased significantly from 7.9% in those aged ≤54 years to 18.4% in patients aged ≥75 years (p < 0.001). The frequency of both pDDIs associated with statins and non-statin pDDIs increased with age. Risk factors for pDDIs in patients aged ≥75 years were arrhythmias, heart failure and the number of pharmacologically active substances prescribed. The more frequent prescription of cardiovascular drugs with a high potential for pDDIs (e.g. amiodarone and digoxin) in patients aged ≥75 years was mainly responsible for the observed increases in statin and non-statin pDDIs in this age group.
Compared with younger patients, elderly dyslipidaemic patients are at a higher risk for clinically relevant pDDIs, mainly because of a higher number of drugs prescribed. In addition, patients aged ≥75 years were prescribed more drugs with a high potential for DDIs, especially drugs used for the treatment of arrhythmias and heart failure. The risk for adverse reactions associated with pDDIs may often be reduced by dose adjustment, close monitoring or selection of an alternative drug.
KeywordsStatin Digoxin Simvastatin Atorvastatin Amiodarone
This study was financially supported by Bristol-Myers Squibb, GmbH, Baar, Switzerland. The sponsors had no influence on the study design, analysis and interpretation of data or writing of the manuscript.
Stephan Krähenbühl is supported by a grant from the Swiss National Science Foundation (310’000-112483/1). Stephan Krähenbühl and Lorenzo Hess have received grants from Bristol-Myers Squibb, GmbH, Baar, Switzerland. Raymond Schlienger is employed by Novartis Pharma, Switzerland. None of the authors has any conflicts of interest that are directly relevant to the content of this manuscript.
- 12.Rätz Bravo AE, Tchambaz L, Krähenbühl-Melcher A, et al. Prevalence of potential drug-drug interactions in ambulatory patients with statin therapy. Schweiz Rundsch Med Prax 2006 Feb 1; 95(5): 139–46Google Scholar
- 13.WHO drug dictionary. Version 01–3, third quarter. Uppsala: WHO Collaborating Centre, 2001Google Scholar
- 14.Thomson Micromedex. DRUG-REAX® System [online]. Available from URL: http://www.thomsonhc.com/home/dispatch [Accessed 2002 Apr 30]
- 15.ICH Topic E2A. Clinical safety data management: definitions and standards for expedited reporting. London: The European Agency for the Evaluation of Medicinal Products, 1994Google Scholar
- 16.Stockley IH, editor. Drug interactions. London: The Pharmaceutical Press, 1999Google Scholar
- 17.Tatro DS, editor. Drug interaction facts™. Updated 2003 Jan. St Louis (MO): Facts and Comparisons, 2003Google Scholar
- 18.e-mediat. Pharmavista databases: interactions [online]. Available from URL: http://www.pharmavista.ch [Accessed 2002 Apr 30]
- 19.Holm S. A simple sequentially rejective multiple test procedure. Scand J Statist 1979; 6: 65–70Google Scholar
- 20.Sauro J, Lewis JR. Estimating completion rates from small samples using binomial confidence intervals: comparisons and recommendations. In: Proceedings of the Human Factors and Ergonomics society: 49th Annual Meeting; 2005 Sep 26–30; Orlando (FL). Santa Monica (CA): Human Factors and Ergonomics Society, 2005: 2100–4Google Scholar
- 24.Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001 May 16; 285(19): 2486–97Google Scholar